Huntsman Corporation
In the published model solve dated 2026-Q2, anchored at $11.69, Huntsman Corporation (HUN) is priced for -0.5% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 24, 2026 from SEC EDGAR filings.
• These shares are no longer priced on Huntsman alone: each one is set to convert into 0.5476 Olin shares under an agreed all-stock merger of equals, with both shareholder votes scheduled for August 25, 2026 [Source: Olin and Huntsman joint announcement, June 16, 2026, and joint proxy statement, July 2026]. • The business underneath that ratio is at a trough: March-quarter revenue of $1,420 million produced a $53 million net loss and $73 million of adjusted EBITDA, net debt leverage reached 6.1
Is HUN overvalued? See what's priced in →
345 institutional managers reported holding HUN in 13F filings for the quarter ended 2026-03-31. 65 opened new positions that quarter. Held by Vanguard Group, BlackRock, AQR Capital, among others. On the short side, 29.0M shares were sold short as of the 2026-06-15 count, about 17% of shares outstanding (8.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
HUN has cut its share count 13.5% over the past five years, spending $1.56B on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $0.84 a share annually. Cash returned over the past three years: $418.00M in dividends and $163.00M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at HUN over the trailing three years: 2024: 1 buy totaling $50k; 2025: 6 buys totaling $1.72M. 16 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
HUN's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-02 | -3.1% | -15.8% |
| 2023-11-02 | -0.7% | +5.3% |
| 2024-02-23 | +7.7% | -8.2% |
| 2024-05-04 | +3.1% | -11.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
HUN's latest 8-K filings: 2026-07-30 (items 2.02, 9.01); 2026-06-16 (items 1.01, 8.01, 9.01); 2026-06-16 (items 7.01, 9.01); 2026-05-01 (items 5.07); 2026-04-30 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 24, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.